Steven E Nissen

Steven E Nissen

UNVERIFIED PROFILE

Are you Steven E Nissen?   Register this Author

Register author
Steven E Nissen

Steven E Nissen

Publications by authors named "Steven E Nissen"

Are you Steven E Nissen?   Register this Author

100Publications

1466Reads

High-Density Lipoprotein-Targeted Therapies-Not Dead Yet-Reply.

JAMA Cardiol 2018 Nov 28. Epub 2018 Nov 28.

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

View Article
November 2018

Nonstatin Therapy for Dyslipidemia.

Circ Res 2018 Oct;123(9):1036-1038

From the Department of Cardiovascular Medicine, Cleveland Clinic, OH.

View Article
October 2018

Warfarin Use Is Associated With Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound.

JACC Cardiovasc Imaging 2018 Sep 19;11(9):1315-1323. Epub 2017 Jul 19.

Cleveland Clinic Coordinating Center for Clinical Research, Cleveland, Ohio; Québec Heart and Lung Institute, Québec, Canada; Department of Medicine, University of Adelaide, Adelaide, Australia. Electronic address:

View Article
September 2018

Randomized Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype-Reply.

JAMA Cardiol 2018 Sep;3(9):897-898

Eli Lilly & Company, Lilly Corporate Center, Indianapolis, Indiana.

View Article
September 2018

Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes.

Eur Heart J 2018 Jul;39(27):2551-2558

Department of Cardiovascular Medicine, Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article
July 2018

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.

J Am Coll Cardiol 2018 Apr;71(16):1741-1751

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio. Electronic address:

View Article
April 2018

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Authors:
Steven E Nissen

Ann Intern Med 2018 Mar;168(5):381-382

Cleveland Clinic, Cleveland, Ohio (S.E.N.).

View Article
March 2018

Results of the GLAGOV trial.

Cleve Clin J Med 2017 Dec;84(12 Suppl 4):e1-e5

Professor of Cardiology, Theme Leader, South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia.

View Article
December 2017

Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.

Atherosclerosis 2017 Aug 15;263:137-144. Epub 2017 Jun 15.

Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, Cleveland, OH, United States; Department of Medicine, University of Adelaide, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia. Electronic address:

View Article
August 2017

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Authors:
Steven E Nissen

Ann Intern Med 2017 08 25;167(4):281-282. Epub 2017 Jul 25.

From Cleveland Clinic, Cleveland, Ohio.

View Article
August 2017

The National Institute for Health and Care Excellence update for stable chest pain: poorly reasoned and risky for patients.

Heart 2017 07 2;103(13):972-974. Epub 2017 May 2.

Department of Cardiology, Cleveland Clinic, Cleveland, Ohio, USA.

View Article
July 2017

Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long-Term Mortality After Noncardiac Vascular Surgery.

J Am Heart Assoc 2017 Jun 6;6(6). Epub 2017 Jun 6.

Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH.

View Article
June 2017

Conflicts of Interest and Professional Medical Associations: Progress and Remaining Challenges.

Authors:
Steven E Nissen

JAMA 2017 May;317(17):1737-1738

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

View Article
May 2017

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

N Engl J Med 2017 05;376(20):1933-1942

From the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland (A.M.L., V.M., E.M., K.W., D.M., S.E.N.); South Australian Heart and Medical Research Institute, University of Adelaide, Adelaide (S.J.N.), and School of Medical Sciences, University of New South Wales, Sydney (P.J.B.) - both in Australia; Eli Lilly, Indianapolis (J.S.R., G.R., B.V., G.W.); Washington Cardiovascular Associates, Medstar Research Institute, Washington, DC (H.B.B.); Centre for Cardiovascular Science, University of Edinburgh, Edinburgh (K.A.A.F.); Beth Israel Deaconess Medical Center, Boston (C.M.G.); Duke University Medical Center, Durham, NC (C.G.); Université Sorbonne Paris 6, ACTION Study Group, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Institut de Cardiologie, Paris (G.M.); Penn Heart and Vascular Center, Philadelphia (D.R.); Columbia University, New York (A.R.T.), and Saratoga Cardiology Associates, Saratoga Springs (D.K.) - both in New York; St. Michael's Hospital, Toronto (S.G.), Recherche Médicale Saint-Jérôme, Saint-Jérôme, QC (Y.P.), and Centre de Santé et de Services Sociaux du Nord de Lanaudière-Centre Hospitalier Régional de Lanaud, Saint-Charles-Borromée, QC (S.K.) - all in Canada; Instituto Cardiovascular de Buenos Aires, Buenos Aires (D.C.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Heart Institute (InCor)-University of São Paulo Medical School, São Paulo (J.C.N.); Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, Mexico (J.L.L.-P.); the First Affiliated Hospital of Harbin Medical University, Harbin, China (W.L.); and South Oklahoma Heart Research, Oklahoma City (N.T.).

View Article
May 2017

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

Authors:
Steven E Nissen

N Engl J Med 2017 04;376(14):1390

Cleveland Clinic, Cleveland, OH

View Article
April 2017

Evolocumab Added to Statins to Reduce Progression of Coronary Atherosclerosis-Reply.

JAMA 2017 04;317(16):1691

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

View Article
April 2017

Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction.

Eur J Prev Cardiol 2017 03 12;24(4):373-381. Epub 2016 Nov 12.

4 South Australian Health and Medical Research Institute and Royal Adelaide Hospital, University of Adelaide, South Australia, Australia.

View Article
March 2017

Statin Intolerance: An Elusive But Morbid Disorder.

Authors:
Steven E Nissen

J Am Coll Cardiol 2017 Mar;69(11):1396-1398

Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. Electronic address:

View Article
March 2017

Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

N Engl J Med 2017 02;376(7):641-651

From the Bariatric and Metabolic Institute (P.R.S., A.A., S.A.B.), Lerner Research Institute (J.P.K.), Cleveland Clinic Coordinating Center for Clinical Research (K.W., C.E.P., S.E.N.), Cole Eye Institute (R.P.S.), and Endocrinology Institute (S.R.K.), Cleveland Clinic, Cleveland; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); and the Section of Nephrology, Baylor College of Medicine, Houston (S.D.N.).

View Article
February 2017

Comparing Coronary Atheroma Progression Rates and Coronary Events in the United States, Canada, Latin America, and Europe.

Am J Cardiol 2016 Dec 31;118(11):1616-1623. Epub 2016 Aug 31.

Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland, Ohio; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article
December 2016

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

N Engl J Med 2016 12 13;375(26):2519-29. Epub 2016 Nov 13.

From the Cleveland Clinic, Cleveland (S.E.N., M.E.H., L.M.W., K.E.W., Q.W., V.M., A.M.L.); Western Sydney University, Campbelltown, NSW, Australia (N.D.Y.); Brigham and Women's Hospital, Harvard Medical School, Boston (D.H.S., P.L.); University Hospital Zurich, Zurich, Switzerland (T.F.L., F.R.); Baylor College of Medicine, Veterans Affairs Medical Center, Houston (D.Y.G.); and State University of New York, Downstate Health Sciences Center (J.S.B.) and Pfizer (M.G., B.B., M.F.B., W.B.), New York.

View Article
December 2016

Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN.

Atherosclerosis 2016 11 15;254:78-84. Epub 2016 Sep 15.

C5Research (C5R), Cleveland Clinic, Cleveland, OH, USA; Department of Medicine, University of Adelaide, Adelaide, Australia; Québec Heart & Lung Institute, Québec City, Québec, Canada. Electronic address:

View Article
November 2016

Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events.

Arterioscler Thromb Vasc Biol 2016 11 11;36(11):2220-2228. Epub 2016 Aug 11.

From the Cleveland Clinic Coordinating Center for Clinical Research (C5R) (R.P., S.E.N., M.S.), and Department of Cardiovascular Medicine (R.P., S.E.N., M.B.E., S.R.K., E.M.T.), Cleveland Clinic, OH; Department of Medicine, University of Adelaide, Australia (R.P., S.J.N.); and South Australian Health and Medical Research Institute, Adelaide, Australia (Y.K., S.J.N.).

View Article
November 2016

U.S. Dietary Guidelines.

Authors:
Steven E Nissen

Ann Intern Med 2016 10;165(8):605-606

From The Cleveland Clinic, Cleveland, Ohio.

View Article
October 2016

Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.

Am J Cardiol 2016 09 15;118(5):647-55. Epub 2016 Jun 15.

Department of Cardiovascular Medicine, Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, Cleveland, Ohio; Hôpital Laval, Québec Heart and Lung Institute, Québec, Québec, Canada. Electronic address:

View Article
September 2016

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.

Hypertension 2016 09 1;68(3):606-13. Epub 2016 Aug 1.

From the Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington (W.B.W.); Takeda Development Center Americas, Inc, Deerfield, IL (C.A.W., S.K.); University of Chicago Medicine, IL (G.L.B.); International Diabetes Center, Park-Nicollet Clinic, Minneapolis, MN (R.M.B.); Brigham and Women's Hospital, Harvard Medical School, Boston, MA (C.P.C.); Memphis Veterans Affairs Medical Center, University of Tennessee College of Medicine (W.C.C.); University of Sheffield, United Kingdom (S.K.H.); Harvard School of Public Health, Boston, MA (C.R.M.); Cleveland Clinic Foundation, OH (S.E.N.); and Université de Lorraine, Nancy, France (F.Z.).

View Article
September 2016

Sex Differences in Nonculprit Coronary Plaque Microstructures on Frequency-Domain Optical Coherence Tomography in Acute Coronary Syndromes and Stable Coronary Artery Disease.

Circ Cardiovasc Imaging 2016 Aug;9(8)

From the South Australian Health & Medical Research Institute, University of Adelaide, Australia (Y.K., P.K., S.J.N.); Department of Cardiovascular Medicine, Cleveland Clinic, OH (R.P., M.H., B.D., K.U., S.R.K., E.M.T.); and Cleveland Clinic Coordinating Center for Clinical Research, OH (R.P., K.U., S.E.N.).

View Article
August 2016

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2016 07 13;375(4):311-22. Epub 2016 Jun 13.

From the University of Texas Southwestern Medical Center, Dallas (S.P.M.); Massachusetts General Hospital, Boston (G.H.D.); Novo Nordisk, Bagsvaerd, Denmark (K.B.-F., P.K., L.S.R., M.S.); Friedrich Alexander University of Erlangen, Erlangen (J.F.E.M.), and St. Josef Hospital, Ruhr University, Bochum (M.A.N.) - both in Germany; Cleveland Clinic, Cleveland (S.E.N.); London School of Hygiene and Tropical Medicine Medical Statistics Unit (S.P.) and Imperial College London (N.R.P.), London; George Washington University Medical Center, Washington, DC (W.M.S.); Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto (B.Z.); International Diabetes Center at Park Nicollet, Minneapolis (R.M.B.); and the University of North Carolina School of Medicine, Chapel Hill (J.B.B.).

View Article
July 2016

Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).

Am Heart J 2016 Jun 17;176:83-92. Epub 2016 Feb 17.

Cleveland Clinic Coordinating Center for Clinical Research (C5R), Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH; Department of Medicine, University of Adelaide, Adelaide, Australia; South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. Electronic address:

View Article
June 2016

U.S. Dietary Guidelines: An Evidence-Free Zone.

Authors:
Steven E Nissen

Ann Intern Med 2016 Apr 19;164(8):558-9. Epub 2016 Jan 19.

View Article
April 2016

IVUS Virtual Histology: Unvalidated Gimmick or Useful Technique?

Authors:
Steven E Nissen

J Am Coll Cardiol 2016 Apr;67(15):1784-1785

Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. Electronic address:

View Article
April 2016

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.

JAMA 2016 Mar;315(10):990-1004

Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Sanford-Burnham Medical Research Institute, Orlando.

View Article
March 2016

Non-invasive volumetric assessment of aortic atheroma: a core laboratory validation using computed tomography angiography.

Int J Cardiovasc Imaging 2016 Jan 12;32(1):121-9. Epub 2015 May 12.

Atherosclerosis Imaging Core Laboratory, Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195, USA.

View Article
January 2016

Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.

Atherosclerosis 2015 Dec 20;243(2):553-9. Epub 2015 Oct 20.

Department of Medicine, University of Adelaide, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia. Electronic address:

View Article
December 2015

Near-Infrared Spectroscopy Enhances Intravascular Ultrasound Assessment of Vulnerable Coronary Plaque: A Combined Pathological and In Vivo Study.

Arterioscler Thromb Vasc Biol 2015 Nov 3;35(11):2423-31. Epub 2015 Sep 3.

From the Cleveland Clinic Coordinating Center for Clinical Research (C5R) (R.P., K.W., K.L.K., K.U., S.E.N.), and Department of Cardiovascular Medicine (R.P., S.R.K., E.M.T., S.E.N.), Cleveland Clinic, OH; Department of Medicine, University of Adelaide, South Australia (R.P., S.J.N.); Frederik Meijer Heart and Vascular Institute, Spectrum Health, Grand Rapids, MI (R.D.M.); InfraRedX Inc., Burlington, MA (S.P.M., S.T.S., J.E.M.); South Australian Health and Medical Research Institute, Adelaide, South Australia (J.A., Y.K., S.J.N.); CVPath Institute, Gaithersburg, MD (R.V.); and Cardiovascular Research Foundation, New York, NY (A.M., G.S.M.).

View Article
November 2015

Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis.

Eur J Prev Cardiol 2015 Oct 31;22(10):1331-9. Epub 2015 Jul 31.

South Australian Health and Medical Research Institute, University of Adelaide, Australia.

View Article
October 2015

Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels.

Atherosclerosis 2015 Oct 8;242(2):490-5. Epub 2015 Aug 8.

South Australian Health & Medical Research Institute, University of Adelaide, Adelaide, Australia.

View Article
October 2015

Changing Continuing Medical Education--Reply.

Authors:
Steven E Nissen

JAMA 2015 Sep;314(10):1074

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

View Article
September 2015

Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter.

Circ Arrhythm Electrophysiol 2015 Aug 10;8(4):772-6. Epub 2015 Jun 10.

From the Minneapolis Heart Institute, MN (J.M.A.); Department of Cardiovascular Medicine, Cleveland Clinic, OH (W.I.S., M. Bhargava, M. Bassiouny, D.J., B.L., M.M., S.E.N., S.P., C.T.-E., K.W., B.L.W.); Brown University, Providence, RI (C.V.); and Department of Internal Medicine, Johns Hopkins Hospital, Baltimore, MD (D.L.).

View Article
August 2015

Statin-induced coronary artery disease regression rates differ in men and women.

Curr Opin Lipidol 2015 Aug;26(4):276-81

aDepartment of Cardiovascular Medicine, C5Research (C5R), Cleveland Clinic, Cleveland, Ohio, USA bSouth Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia.

View Article
August 2015

Reforming the continuing medical education system.

Authors:
Steven E Nissen

JAMA 2015 May;313(18):1813-4

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

View Article
May 2015

Atheroma progression in hyporesponders to statin therapy.

Arterioscler Thromb Vasc Biol 2015 Apr 26;35(4):990-5. Epub 2015 Feb 26.

From the South Australian Health and Medical Research Institute, Heart Health Theme, University of Adelaide, Adelaide, Australia (Y.K., S.J.N.); and C5 Research (J.S.J., K.W., K.U., R.P., S.E.N.) and Department of Cardiovascular Medicine, Heart and Vascular Institute (R.P., E.M.T., S.E.N.), Cleveland Clinic, OH.

View Article
April 2015

Impact of statins on serial coronary calcification during atheroma progression and regression.

J Am Coll Cardiol 2015 Apr;65(13):1273-1282

Cleveland Clinic Coordinating Center for Clinical Research (C5R), Cleveland, Ohio; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio. Electronic address:

View Article
April 2015

Commentary: confidentiality of interim trial data-the emerging crisis.

Authors:
Steven E Nissen

Clin Trials 2015 Feb 18;12(1):15-7. Epub 2014 Dec 18.

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA

View Article
February 2015

Prevention guidelines: bad process, bad outcome.

Authors:
Steven E Nissen

JAMA Intern Med 2014 Dec;174(12):1972-3

Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio.

View Article
December 2014

Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis.

Cardiovasc Diagn Ther 2014 Dec;4(6):460-9

1 South Australian Health & Medical Research Institute, University of Adelaide, Adelaide, Australia ; 2 Cleveland linic Coordinating Center for Clinical Research, Cleveland, Ohio, USA ; 3 Department of Cardiovascular Medicine, Heart & Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.

View Article
December 2014

Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.

Arterioscler Thromb Vasc Biol 2014 Nov 11;34(11):2465-72. Epub 2014 Sep 11.

From the Department of Cardiovascular Medicine (R.P., S.E.N.) C5Research (R.P., S.E.N., M.S., S.J.N.), Cleveland Clinic, OH; Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, TX (C.M.B.); Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia (P.J.B.); INSERM Dyslipidaemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France (M.J.C.); West German Heart Center, Essen, Germany (R.E.); Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (P.L.); AstraZeneca, Wilmington, DE (J.S.R.); and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, South Australia, Australia (K.U., Y.K., S.J.N.).

View Article
November 2014

Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.

Am J Cardiol 2014 Nov 27;114(10):1465-72. Epub 2014 Aug 27.

South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. Electronic address:

View Article
November 2014

HCAHPS Survey Results: Impact of Severity of Illness on Hospitals' Performance on HCAHPS Survey Results.

J Patient Exp 2014 Nov 1;1(2):16-21. Epub 2014 Nov 1.

Medicine Institute, Lerner College of Medicine, Cleveland Clinic.

View Article
November 2014

Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN.

JACC Cardiovasc Imaging 2014 Oct 17;7(10):1013-22. Epub 2014 Sep 17.

C5Research, Cleveland Clinic, Cleveland, Ohio; South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia. Electronic address:

View Article
October 2014

Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques.

Eur Heart J Cardiovasc Imaging 2014 Sep 29;15(9):1035-41. Epub 2014 Apr 29.

South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia.

View Article
September 2014

Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.

Am J Cardiol 2014 Sep 18;114(5):681-5. Epub 2014 Jun 18.

Heart Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia. Electronic address:

View Article
September 2014

Frequency-domain optical coherence tomographic analysis of plaque microstructures at nonculprit narrowings in patients receiving potent statin therapy.

Am J Cardiol 2014 Aug 6;114(4):549-54. Epub 2014 Jun 6.

Heart Health, South Australian Health & Medical Research Institute, University of Adelaide, Adelaide, South Australia, Australia.

View Article
August 2014

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study.

Lancet Diabetes Endocrinol 2014 Jun 18;2(6):455-63. Epub 2014 Feb 18.

Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. Electronic address:

View Article
June 2014

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

N Engl J Med 2014 May 31;370(21):2002-13. Epub 2014 Mar 31.

From the Bariatric and Metabolic Institute (P.R.S., S.A.B., A.A.), Lerner Research Institute (J.P.K.), Heart and Vascular Institute (K.W., C.E.P., E.S.H.K., S.E.N.), Urological and Kidney Institute (S.D.N.), and Endocrinology Institute (S.R.K.), Cleveland Clinic, Cleveland; and Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School - both in Boston (D.L.B.).

View Article
May 2014

Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound.

Atherosclerosis 2014 Feb 19;232(2):377-83. Epub 2013 Dec 19.

Department of Cardiovascular Medicine, Heart & Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

View Article
February 2014

Rosiglitazone: a case of regulatory hubris.

Authors:
Steven E Nissen

BMJ 2013 Dec 11;347:f7428. Epub 2013 Dec 11.

chairman of cardiovascular medicine, Cleveland Clinic, Cleveland, Ohio.

View Article
December 2013

C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.

Circulation 2013 Nov 16;128(22):2395-403. Epub 2013 Sep 16.

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH (R.P., S.E.N., K.U., Y.K., S.J.N.); Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (P.L.); C5Research, Cleveland Clinic, Cleveland, OH (M.S.); Section of Cardiovascular Research, Baylor College of Medicine, and the Methodist DeBakey Heart and Vascular Center, Houston, TX (C.M.B.); Centre for Vascular Research, University of New South Wales, Sydney, Australia (P.J.B.); INSERM Dyslipidaemia and Atherosclerosis Research Unit, Hôpital de la Pitié, Paris, France (M.J.C.); West German Heart Center, Essen, Germany (R.E.); AstraZeneca, Wilmington, DE (J.S.R.); and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia (S.J.N.).

View Article
November 2013

Progression of coronary atherosclerosis in African-American patients.

Cardiovasc Diagn Ther 2013 Sep;3(3):161-9

South Australian Health & Medical Research Institute, University of Adelaide, Adelaide, Australia;

View Article
September 2013